Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan
ConclusionsRDW, a routinely available and inexpensive biomarker, provides incremental prognostic information when added to established predictors. Compared with valsartan, sacubitril/valsartan led to a small reduction in RDW.
Source: ESC Heart Failure - Category: Cardiology Authors: Jawad H. Butt,
Kirsty McDowell,
Toru Kondo,
Akshay S. Desai,
Martin P. Lefkowitz,
Milton Packer,
Mark C. Petrie,
Marc A. Pfeffer,
Jean L. Rouleau,
Muthiah Vaduganathan,
Michael R. Zile,
Pardeep S. Jhund,
Lars K øber,
Scott Solomon,
John J.V Tags: Original Article Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | Diovan | Heart | Heart Disease | Heart Failure